🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

BostonGene and Exigent Genomic INsight Study

Recruitingn/aAges 18 Years - anyAllBostonGene
NCT06272864 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The BEGIN Study by BostonGene and Exigent Genomic INsight evaluates the efficacy of comprehensive molecular testing in advanced cancer patients. Using the BostonGene Tumor Portrait test, the study aims to identify actionable findings, assess feasibility, and determine patient enrollment in clinical trials. Four cohorts of 100 patients each will be studied over two years, focusing on treatment decisions and patient outcomes. This study seeks to demonstrate the clinical utility of genomic testing in guiding therapy for advanced cancer patients in community settings.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients must have a confirmed malignancy of: Locally recurrent, unresectable, or metastatic breast cancer or; Unresectable stage III or metastatic non-small cell lung cancer or; Unresectable or metastatic melanoma or; Locally advanced or metastatic l sarcoma. * Life expectancy \> 3 months as per the treating physician * Willingness to provide informed consent * Living in the United States at time of enrollment * Agree to participate in genomic and molecular profiling Exclusion Criteria: * not meeting the inclusion criteria
💊

What it tests

  • Not listed
📍

Where

7 sites
Highlands Oncology Group
Rogers, United States
Stockton Hematology Oncology Medical Group
Stockton, United States
Fort Wayne Medical Oncology and Hematology
Fort Wayne, United States
New Mexico Cancer Center
Albuquerque, United States
Oklahoma Cancer Specialists and Research Institute
Tulsa, United States
Oncology Consultants
Houston, United States
Northwest Medical Specialities
Puyallup, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy